CinCor Pharma, Inc.
CinCor Pharma, Inc. (CINC) is a publicly traded company in the Unknown sector. Across all available filings, 16 corporate insiders have executed 54 transactions totaling $133.4M, demonstrating a bullish sentiment with $133.2M in net insider flow. The most recent transaction on Feb 24, 2023 involved a transaction of 12,500 shares valued at $0.
CINC Insider Activity Summary
Who Is Buying CINC Stock?
No significant insider buying has been recorded for CINC in the recent period.
Who Is Selling CINC Stock?
No significant insider selling has been recorded for CINC in the recent period.
Is CinCor Pharma, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for CINC is bullish with an Insider Alignment Score of 100/100 and a net flow of $133.2M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
CINC Frequently Asked Questions
Understanding CINC Insider Activity
Insider trading at CinCor Pharma, Inc. (CINC) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 16 insiders are actively trading CINC stock, having executed 54 transactions in the past 90 days. The most active insider is Coinvestments Iii, Llc Gap (Executive), who has made 3 transactions totaling $29.7M.
Related Tools
Track CinCor Pharma, Inc. Insider Activity
Get notified when executives and directors at CINC file new Form 4 transactions